Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
03/2010
03/10/2010EP2161291A2 Polymer
03/10/2010EP1951235B1 Novel crystal forms of irinotecan hydrochloride
03/10/2010EP1807420B1 Trisubstituted thiophenes as progesterone receptor modulators
03/10/2010EP1781296B1 Quinazoline derivatives and their use in the treatment of thrombocythemia
03/10/2010EP1682541B1 Method for producing tiotropium salts
03/10/2010EP1511752B3 Camptothecins with a modified lactone ring
03/10/2010EP1445257B1 2h-1-benzopyran compounds for use in a photochromic material
03/09/2010US7674907 2,3-diphenyl-N-((2S)-tetrahydro-2-furanylmethyl)furo[2,3-b]pyridin-4-amine; arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis
03/09/2010US7674803 Thiazolypiperidine derivatives as MTP inhibitors
03/09/2010CA2493313C Novel benzodioxoles
03/09/2010CA2421819C Isoquinolinone potassium channel inhibitors
03/04/2010WO2010025337A1 Method of treating ras associated cancer
03/04/2010US20100056511 2- [ (2-substituted) -ind0lizin-3-yl] -2-oxo-acetamide derivatives as antifungal agents
03/04/2010US20100056503 Compounds for modulating integrin CD11b/CD18
03/04/2010US20100056498 Substituted monocyclic cgrp receptor antagonists
03/03/2010EP2158206A1 Substituted furopyrimidines and use thereof
03/03/2010EP1885727B1 Syntheses and preparations of narwedine and related novel compounds
03/03/2010CN101659668A Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
03/03/2010CN101659667A Method for purifying irinotecan hydrochloride
03/02/2010US7671190 Transformed host cells that make the anticancer polyketides herbimycin and geldanamycin; biosynthesis
03/02/2010US7671079 Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
03/02/2010US7671068 N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
03/02/2010US7671067 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
02/2010
02/25/2010WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010021149A1 Spiro compound capable of inhibiting acid secretion
02/25/2010WO2010020548A1 Glyt1 receptor antagonists
02/25/2010WO2008139452A3 Selective bromination of perylene diimides and derivatives thereof under mild conditions
02/25/2010US20100048610 Carbinol derivatives having cyclic linker
02/25/2010US20100048600 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
02/25/2010US20100048599 Compounds As Kinase Inhibitors
02/25/2010US20100048591 Chemical compounds and processes
02/25/2010US20100048554 Spirocyclic Cyclohexane Compounds
02/25/2010US20100048553 Spirocyclic Cyclohexane Compounds
02/25/2010US20100048551 Tricyclic Compounds Useful as Inhibitors of Kinases
02/25/2010US20100048537 Heteroaryl derivatives
02/25/2010US20100048532 Benzimidazole Derivatives as Selective Acid Pump Inhibitors
02/25/2010US20100048531 GlyT1 RECEPTOR ANTAGONISTS
02/25/2010CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/24/2010EP2155722A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
02/24/2010CN101657456A pyrano-pyrazole-amines
02/24/2010CN101654456A Water-soluble derivants containing 10-hydroxycamptothecine and preparation method thereof
02/24/2010CN100591680C Dihydrotetrabenazines and pharmaceutical compositions containing same
02/24/2010CN100591676C 2- and 2,5-substituted phenylketo-enols
02/23/2010US7666880 Hydroxamate compounds which are inhibitors of histone deacetylase; may be useful as medicaments for treatment of proliferative disorders as well as other diseases involving, relating to, or associated with enzymes having histone deacetylase activities such as neurodegenerative, cardiovascular disorders
02/23/2010US7666879 enzyme inhibitor; 2-{2-Fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide; angiogenesis inhibitor; antitumor agent; treating hyperglycemia, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, autoimmune diseases, inflammation, and eye disorders
02/23/2010US7666869 Nitrogen-containing 5-membered ring compound
02/18/2010WO2009132313A3 Morphinan derivatives of organic and inorganic acids
02/18/2010US20100041900 Isolation of lactam compound from adlay bran and its use on anti-proliferative cancer cells
02/18/2010US20100041690 Co-Administration of Dopamine-Receptor Binding Compounds
02/18/2010US20100041676 Kinase inhibitors
02/18/2010US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth
02/17/2010EP2154134A1 Process for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole.
02/17/2010EP1902026B1 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
02/17/2010CN101652372A spiro-pyrano-pyrazole derivatives
02/17/2010CN101648950A Tiotropium salts, pharmaceutical composition and uses thereof
02/17/2010CN101648947A 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
02/17/2010CN100590124C Tricyclic androgen receptor modulator compounds and method
02/16/2010US7662846 Selective spirocyclic glucocorticoid receptor modulators
02/16/2010US7662833 metalloproteinases inhibitor, particular Peptide Deformylase (Pdf) inhibitor; antibiotic; e.g. 2-(6-fluoro-imidazo[1,2-a]pyridin-3-ylamino)-N-hydroxy-acetamide
02/16/2010US7662832 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
02/16/2010US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis
02/16/2010CA2539985C Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
02/16/2010CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors
02/16/2010CA2442882C Sulphones which modulate the action of gamma-secretase
02/16/2010CA2415295C Radioligand and binding assay
02/16/2010CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound
02/16/2010CA2346082C Tricyclic .delta.3-piperidines as pharmaceuticals
02/16/2010CA2341707C Pyrimidine derivatives
02/11/2010WO2010017418A1 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
02/11/2010WO2010015985A1 Tricyclic alkylaminomethyloxazolidinone derivatives
02/11/2010WO2009138386A3 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
02/11/2010US20100034741 Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor
02/11/2010CA2731365A1 Tricyclic alkylaminomethyloxazolidinone derivatives
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010CN101646678A Heteroaryl derivative
02/10/2010CN101646677A Process for making asenapine
02/09/2010US7659283 Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases
02/09/2010US7659265 5-(4,4-dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbothioamide; menopause therapy; contraceptive; anticancer agents
02/09/2010CA2430673C N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
02/09/2010CA2299754C Hydroxy-substituted n-alkoxy hindered amines
02/09/2010CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
02/04/2010WO2010014930A2 Therapeutic agents
02/04/2010WO2010014516A1 Nitro derivatives of furasemide and their use as diuretics
02/04/2010WO2010012789A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
02/04/2010WO2010012714A1 Nitrogenated derivatives of pancratistatin
02/04/2010WO2010012381A1 Streptospirole derivatives
02/04/2010WO2009001129A9 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors
02/04/2010US20100029953 Phenyltetraene-based nonlinear optical chromophores
02/04/2010US20100029707 Tricyclic compound and medical use thereof
02/04/2010US20100029678 Diuretics
02/04/2010US20100029639 Ion channel modulating compounds and uses thereof
02/04/2010US20100029632 improved pharmacokinetics
02/04/2010US20100029625 Therapeutic Agent for Restenosis
02/04/2010US20100029614 Spirocyclic heterocyclic derivatives and methods of their use
02/04/2010CA2732628A1 Therapeutic agents
02/04/2010CA2731957A1 Nitro derivatives of furasemide and their use as diuretics
02/04/2010CA2731901A1 Nitrogenated derivatives of pancratistatin
02/04/2010CA2731405A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
02/03/2010EP2148882A1 Process for making topotecan
02/03/2010EP2148877A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 298